Skip to content

ThermoGenesis to outline product strategy in COVID-19 at conference

September 2, 2020

ThermoGenesis Holdings (NASDAQ:THMO) along with its joint venture, ImmuneCyte plans to roll out a comprehensive diagnostic and therapeutic product line to fight COVID-19 pandemic.

The multi-pronged strategy will combine diagnostic, therapeutic and service offerings to better detect, track and fight coronavirus. Further details will be included in the company’s presentation at the LD Micro 500 Conference today at 5 p.m. EST.

From → Uncategorized

Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: